Medline ® Abstract for Reference 242
of 'Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials'
Segal NH, Reidy-Lagunes D, Capanu M, et al. Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer patients who have progressed on a bavacizumab containing regimen (the BOND 2.5 study) (Abstract # 4087). J Clin Oncol 2009; 27:189s.
no abstract available